Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.
Lacrimal glands (LGs) of male non-obese diabetic (NOD) mice display many features of human LGs in patients afflicted with the autoimmune disease Sjögren's syndrome (SS), including the loss of secretory functions and a lymphocytic infiltration into the glands by 4 months of age. So far, research has mainly focused on the intracellular events that are involved in initiating LG dysfunction; however, the impact of SS on extracellular matrix (ECM) structures of the diseased LGs has not yet been determined. In this study we identified and compared LG ECM formation and integrity of age-matched male healthy (BALB/c) and diseased (NOD) mice. LG tissues were examined using routine histological, biochemical, immunohistochemical and gene expression analysis. Multiphoton imaging and second-harmonic generation (SHG) microscopy permitted the non-invasive analysis of major LG ECM structures including collagen- and elastin-containing fibers. Biochemical testing demonstrated a significant loss of collagen, glycosaminoglycans and desmosine in NOD LGs when compared to healthy BALB/c LGs. Immunohistochemical staining and gene expression analysis confirmed this disease-related alteration of LG ECM structures. Furthermore, laser-induced autofluorescence and SHG microscopy revealed dramatic changes in the structural organization of most collagenous and elastic fibers of the diseased LG tissues that were more pronounced than those displayed by histological analysis. Our results clearly show an enhanced degradation of ECM proteins accompanied by the severe disorganization and deformation of ECM structures of diseased LG tissues. These new insights into the involvement of ECM degradation in SS may lead to novel therapies for patients suffering from dry eye disease.
Schenke-Layland
Katja
K
Cardiovascular Research Laboratory, David Geffen School of Medicine at UCLA, Los Angeles/CA 90095-1760, USA. kschenkelayland@mednet.ucla.edu
Xie
Jiansong
J
Angelis
Ekaterini
E
Starcher
Barry
B
Wu
Kaijin
K
Riemann
Iris
I
MacLellan
W Robb
WR
Hamm-Alvarez
Sarah F
SF
D000818:Animals; D003094:Collagen / Q000235:genetics / Q000378:metabolism; D003895:Desmosine / Q000378:metabolism; D005109:Extracellular Matrix / Q000737:chemistry / Q000378:metabolism*; D016326:Extracellular Matrix Proteins / Q000235:genetics / Q000378:metabolism; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D007765:Lacrimal Apparatus / Q000166:cytology* / Q000378:metabolism / Q000473:pathology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D016688:Mice, Inbred NOD; D020411:Oligonucleotide Array Sequence Analysis; D012859:Sjogren's Syndrome / Q000473:pathology* / Q000503:physiopathology
D016326:Extracellular Matrix Proteins; D006025:Glycosaminoglycans; D003895:Desmosine; D003094:Collagen
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3293-302
16877394
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12485-90
11606713
J Clin Invest. 2005 Sep;115(9):2363-72
16138190
Z Zellforsch Mikrosk Anat. 1973 Nov 15;144(4):453-66
4793164
J Biol Chem. 2002 Oct 25;277(43):40919-29
12167638
Mol Vis. 2004 Apr 16;10:281-8
15105792
Exp Eye Res. 2006 Jan;82(1):33-45
16005870
Stem Cells. 2007 Jun;25(6):1529-38
17363553
Arthritis Rheum. 2000 Dec;43(12):2807-17
11145040
Acta Ophthalmol (Copenh). 1971;49(5):779-89
5171922
J Biomed Opt. 2005 Mar-Apr;10(2):024017
15910091
J Clin Invest. 1983 Jul;72(1):52-62
6603476
Ultrastruct Pathol. 1997 Nov-Dec;21(6):537-44
9355236
J Immunol. 2000 Jul 15;165(2):779-85
10878351
Anat Histol Embryol. 2003 Oct;32(5):257-62
12969024
Arch Oral Biol. 1999 May;44 Suppl 1:S21-5
10414851
J Oral Med. 1975 Jan-Mar;30(1):24-8
45939
Arthritis Rheum. 2003 Sep;48(9):2573-84
13130477
Differentiation. 2003 Jun;71(4-5):291-8
12823230
Clin Exp Immunol. 1999 Oct;118(1):154-63
10540173
J Rheumatol. 1998 Dec;25(12):2371-80
9858432
Rheumatology (Oxford). 2004 Dec;43(12):1476-9
15316122
Int Immunol. 2000 Mar;12(3):313-24
10700466
Arch Histol Cytol. 2003 Dec;66(5):407-18
15018143
Arch Oral Biol. 1996 Oct;41(10):951-8
9031702
Scand J Immunol. 2003 Nov;58(5):550-65
14629627
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4293-301
15557435
J Clin Invest. 1996 Apr 15;97(8):1969-77
8621782
Exp Eye Res. 2004 Nov;79(5):665-75
15500825
J Clin Invest. 2000 Jan;105(1):21-34
10619858
Aust Dent J. 1982 Oct;27(5):288-90
6962691
J Morphol. 1989 Jul;201(1):39-57
2664187
Invest Ophthalmol Vis Sci. 1989 Sep;30(9):2002-11
2777519
Exp Eye Res. 2000 Jul;71(1):11-22
10880272
Adv Drug Deliv Rev. 2006 Sep 15;58(7):878-96
17011064
J Rheumatol. 1996 Feb;23(2):313-20
8882038
Ann Rheum Dis. 2006 Feb;65(2):178-83
16014676
Arch Histol Cytol. 1996 Dec;59(5):505-13
9037387
Anat Embryol (Berl). 1998 Jul;198(1):1-12
9683063
J Cell Biochem. 2001 Mar 26;81(2):220-8
11241662
Arch Oral Biol. 1997 Jun;42(6):443-54
9382709
Matrix Biol. 1998 Oct;17(5):335-47
9822200
Arthritis Rheum. 1986 May;29(5):577-85
3718551
Mayo Clin Proc. 2001 Jun;76(6):593-9
11393497
Clin Immunol. 2002 Nov;105(2):223-32
12482397
J Histochem Cytochem. 2005 Apr;53(4):431-43
15805418
Proc Natl Acad Sci U S A. 1997 May 27;94(11):5767-71
9159148
Nat Rev Immunol. 2002 May;2(5):309-22
12033737
Anat Rec. 1992 Nov;234(3):335-47
1443662
J Leukoc Biol. 2000 Feb;67(2):149-59
10670574
J Immunol. 1996 Jan 1;156(1):1-4
8598448
Connect Tissue Res. 1995;31(2):133-40
15612329
Arch Pathol. 1972 Aug;94(2):187-91
4114784
J Clin Immunol. 2006 Jul;26(4):299-307
16652230
Arch Med Res. 2006 Nov;37(8):921-32
17045106
Lancet. 2001 Mar 3;357(9257):688-9
11247557
Scand J Immunol. 2005 Jan;61(1):36-50
15644121